Novel Series of Achiral, Low Molecular Weight, and Potent HIV-1 Protease Inhibitors

Journal of the American Chemical Society

Volumn 116, Issue 15, 1994, Pages 6989-6990

  Para, Kimberly S ^a   Lunney, Elizabeth A ^a   Ortwine, Daniel F ^a   Dunbar, James B ^a   Tait, Bradley D ^a   Domagala, John M ^a   Humblet, Christine ^a   Sawyer, Tomi K ^a   Ferguson, Donna ^a   Tummino, Peter J ^a   Hupe, Donald ^a   Bhat, T N ^b   Liu, Beishan ^b   Baldwin, Eric T ^b   Erickson, John W ^b   Guerin, Diego M A ^c   Vara Prasad, J V N ^c  

^a PFIZER INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Universidad Nacioral del Sor ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 6 PHENYL 3 (PHENYLTHIO)PYRAN 2 ONE; ANTIVIRUS AGENT; PROTEINASE INHIBITOR; PYRAN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME BINDING; HUMAN IMMUNODEFICIENCY VIRUS 1; STRUCTURE ACTIVITY RELATION; X RAY ANALYSIS;

EID: 0028094959     PISSN: 00027863     EISSN: 15205126     Source Type: Journal    
DOI: 10.1021/ja00094a085     Document Type: Article

References (27)

1. Mitsuya, H.; Yarchoan, R.; Broder, S. Science 1990, 249, 1533 and references therein.
2. Meek, T. D. J. Enzyme Inhib. 1992, 6, 65 and references therein.
3. Plattner, J. J.; Norbeck, D. W. In Drug Discovery Technologies; Clark, C. R., Moos, W. H., Eds.; Ellis Horwood: Chichester, England, 1990; pp 92-126.
4. Kempf, D. J.; Codacovi, L.; Wang, X. C.; Kohlbrenner, W. E.; Wideburg, N. E.; Saldivar, A.; Vasavanonda, S.; Marsh, K. C.; Bryant, P.; Sham, H. L.; Green, B. E.; Betebenner, D. A.; Erickson, J. N.; Norbeck, D. W. J. Med. Chem. 1993, 36, 320 and references therein.
5. Askin, D.; Eng,K. K.; Eossen, K.; Purick, R. M.; Wells, K. M.; Volante, R. P.; Reider, P. J. Tetrahedron Lett. 1994, 35, 673.
6. Houpis, I. N.; Molina, A.; Reamer, R. A.; Lynch, J. E.; Volante, R. P.; Reider, R. A. Tetrahedron Lett. 1993, 34, 2593.
7. Friedman, S. H.; DeCamp, D. L.; Sijbesma, R. P.; Srdanov, G.; Wudl, F.; Kenyon, G. C. J. Am. Chem. Soc. 1993, 115, 6506 and references therein.
8. Brinkworth, R. I.; Stoermer, M. J.; Fairlie, D. P. Biochem. Biophys. Res. Commun. 1992, 188, 631-637 and references therein.
9. Paris, A.; Strukelj, B.; Renko, M.; Turk, V.; Pukl, M.; Umek, A.; Korant, B. D. J. Nat. Prod. 1993, 56, 1426 and references therein.
10. Olson, G. L.; Bolin, D. R.; Bonner, M. P.; Bos, M.; Cook, C. M.; Fry, D. C.; Graves, B. J.; Hatada, M.; Hill, D. E.; Kahn, M.; Madison, V. S.; Rusiecki, V. K.; Sarabu, R.; Sepinwall, J.; Vincent, G. P.; Voss, M.E. J. Med. Chem. 1993, 21, 3039 and references therein.
11. Tummino, P. J. 1st National Conferences on Human Retroviruses in Related Infections, Washington, DC, Dec. 12-16, 1993.
12. Luly, J. R.; Yi, N.; Soderquist, J.; Stein, H.; Cohen, J.; Perun, T. J.; Plattner, J. J. J. Med. Chem. 1987, 30, 1609.
13. Vara Prasad, J. V. N.; Houseman, K.; Mueller, R.; Rich, D. H. In Peptides 1992; Schneider, C. H., Eberle, A. N. Eds.; ESCOM Science Publishers BV: Leiden, the Netherlands, 1993; pp 629-630.
14. Goodsell, D. S.; Olson, A. J. Proteins: Struct., Funct. Genet. 1990, 8, 195.
15. Miller, M.; Schneider, J.; Sathyanarayana, B. K.; Toth, M. V.; Marshall, G. R.; Clawson, L.; Selk, L.; Kent, S. B. H.; Wlodawer, A. Science 1989, 246, 1149.
16. Erickson, J. W. Perspect. Drug Discovery Des. 1993, 1, 109 and references therein.
17. Lunney, E. A.; Hagen, S. E.; Domagala, J.; Humblet, C; Tait, B.; Warmus, J.; Wilson, M.; Ferguson, D.; Hupe, D.; Tummino, P. J.; Baldwin, E.; Bhat, T. N.; Liu, B.; Erickson, J. W. J. Med. Chem., in press. A similar observation was made with coumarin analogues.
18. Lam, P. Y. S.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; Bacheler, L. T.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, Y. N.; Chang, C.-H.; Weber, P. C.; Jackson, D. A.; Sharpe, T. R.; Erickson-Vitanen, S. Science 1994, 263, 380.
19. While our work was in progress, the following publication appeared, in which an enol moiety in the inhibitor is reported; Vaillancourt, M.; Vanasse, B.; Cohen, E.; Sauve, G. Bioorg. Med. Chem. Lett. 1993, 3, 1169.
20. Hosur, M. V.; Bhat, T. N.; Kempf. D. J.; Baldwin, E. T.; Liu, B.; Gulnik, S.; Wideburg, N. E.; Norbeck, D. W.; Appelt. K.; Erickson, J. W. J. Am. Chem.Soc. 1994, 116, 847.
21. Appelt, K. Perspeci. Drug Discovery Des. 1993, 1, 23.
22. Rich, D. H.; Sun, C.-Q.; Vara Prasad, J. V. N.; Pathiasseril, A.; Tolh. M. V.; Marshall, G. R.; Clare, M.; Mueller, R. A.; Houseman, K. J. Med. Chem. 1991, 34, 1222.
23. Griffiths, J. T.; Phylip. L. H.; Konvalinka. J.; Strop, P. Gustchina, A.; Wlodawer, A.; Davenport. R. J.; Briggs, R.; Dunn, B. M.; Kay, J. Biochemistry 1992, 31, 5193.
24. Thompson, W. J.; Fitzgerald, P. M. D.; Holloway. M. K.; Emini, E. A.: Darke, P. L.; McKeever, B. M.; Schleif, W. A.: Quintero, J. C.; Zugay, J. A.; Tucker. T. J.; Schwering, J. E.; Homnick, C. P.; Nunberg, J.; Springer, J. P.; Huff. J. R. J. Med. Chem. 1992, 35, 1685.
25. Rich, D. H. J. Med. Chem 1985, 28, 263.
26. Rich, D. H. Perspect. Med. Chem.; Testa, B., Ed.; Verlag Helvitica Chim. Acta: Basel, Switzerland, 1993; pp 15-25.
27. Rapundalo, S. R. Unpublished results. Our initial results on similar pyronc analogues with Other aspartic protease inhibitors, i.e., Renin, Cathepsirt-E, Cathepsin-D, showed that these are al least 1000-fold selective for HIV PR.